U.S. Stocks Dip, Q32 Bio Shares Surge 171% After $12M Deal

US stocks traded lower on Monday, with the Dow Jones falling 0.42% to 47,515.41. Energy shares jumped 1%, while communication services stocks fell 1.2%. Q32 Bio's shares surged 171% to $5.91 after the company sold its Phase 2 complement inhibitor ADX-097 to Akebia for $12 million upfront and potential milestone and royalty payments up to $592 million. Asian markets closed mixed, with Japan's Nikkei dipping 1.89%. European shares were mostly lower, with the eurozone's STOXX 600 falling 0.4%.